ImmunityBio (IBRX) Goodwill & Intangibles (2013 - 2026)

ImmunityBio (IBRX) has 13 years of Goodwill & Intangibles data on file, last reported at $12.9 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $12.9 million, down 16.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (down 16.56% YoY), and the FY2025 annual result was $14.0 million, down 12.43% from the prior year.
• Goodwill & Intangibles retreated to $12.9 million in Q1 2026 per IBRX's latest filing, from $14.0 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $22.3 million in Q1 2022 and troughed at $12.9 million in Q1 2026.
• A 5-year average of $17.4 million and a median of $16.6 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2026: Goodwill & Intangibles jumped 1454.17% in 2022, then decreased 16.56% in 2026.
• A 5-year view of Goodwill & Intangibles shows it stood at $20.0 million in 2022, then dropped by 14.55% to $17.1 million in 2023, then retreated by 6.79% to $15.9 million in 2024, then retreated by 12.43% to $14.0 million in 2025, then slipped by 7.65% to $12.9 million in 2026.
• Business Quant data shows IBRX's Goodwill & Intangibles at $12.9 million in Q1 2026, $14.0 million in Q4 2025, and $14.5 million in Q3 2025.